(Q40797068)

23 September 2017

title

Development of a suspension packaging cell line for production of high titre, serum-resistant murine leukemia virus vectors (English)

1 reference

23 September 2017

0 references

murine leukemia virus

object named as

murine leukemia virus

1 reference

Pizzato M

1

1 reference

23 September 2017

Merten OW

series ordinal

2

1 reference

23 September 2017

Blair ED

series ordinal

3

1 reference

23 September 2017

Takeuchi Y

series ordinal

4

1 reference

23 September 2017

publication date

1 May 2001

1 reference

23 September 2017

1 reference

23 September 2017

volume

8

1 reference

23 September 2017

issue

10

1 reference

23 September 2017

page(s)

737-745

1 reference

Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

A novel human amphotropic packaging cell line: high titer, complement resistance, and improved safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

Production of a highly cytopathic HIV-1 isolate from a human mucosal epithelial cell line cultured on microcarrier beads in serum-free medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

Increased yield of mouse mammary tumor virus (MMTV) by cultivation of monolayer-derived mammary tumor cells in suspension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

Optimization of cell culture conditions for production of biologically active proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

Retroviral-mediated gene transfer into hepatocytes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

Retrovirus-mediated gene transfer into human CD34+38low primitive cells capable of reconstituting long-term cultures in vitro and nonobese diabetic-severe combined immunodeficiency mice in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

Improved methods of retroviral vector transduction and production for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

Kinetics of retroviral production from the amphotropic ΨCRIP murine producer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

Constitutive production of a murine retrovirus in the human B-lymphoblastoid cell line, DG-75.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

Analysis of 4070A envelope levels in retroviral preparations and effect on target cell transduction efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

Comparison of different bioreactor systems for the production of high titer retroviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

Comparison of efficiency of infection of human gene therapy target cells via four different retroviral receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

High-titer packaging cells producing recombinant retroviruses resistant to human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

7 January 2021

Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

7 January 2021

Virus production with a newly developed microcarrier system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

7 January 2021

Production of reovirus type-1 and type-3 from Vero cells grown on solid and macroporous microcarriers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

7 January 2021

Level of ICAM-1 surface expression on virus producer cells influences both the amount of virion-bound host ICAM-1 and human immunodeficiency virus type 1 infectivity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

7 January 2021

Kinetics of retrovirus production and decay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

7 January 2021

Industrial-scale production of inactivated poliovirus vaccine prepared by culture of Vero cells on microcarrier

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

7 January 2021

Retroviral vector targeting to melanoma cells by single-chain antibody incorporation in envelope

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301457

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301457

1 reference

Dimensions Publication ID

23 September 2017

1041535395

0 references

1 reference